Many stroke patients not screened for osteoporosis, despite known risks

April 25, 2019

DALLAS, April 25, 2019 -- The majority of stroke survivors are not screened or treated for osteoporosis, broken bones, or fall risk -- despite stroke being a risk factor for these conditions. The risk is up to four times greater than in healthy people, according to new research in the American Heart Association's journal Stroke.

Stroke survivors often face reduced mobility -- a trait that decreases bone mineral density and increases risk for bone breaks.

Less than one-third of older women living in the United States are screened for osteoporosis and the treatment rate for some high-risk patients tops out at 30 percent.

"Our study adds to previous research that found despite an increased risk, only a small number of people who have recently had a stroke are tested and treated for osteoporosis," said Moira Kapral, M.D., M.Sc., FRCPC, lead author of the study and professor of medicine and director of the division of general internal medicine at the University of Toronto in Canada.

Researchers identified stroke survivors age 65 and older who either had visited the emergency department or had been hospitalized for strokes (ischemic or intracerebral hemorrhage) between July 1, 2003 and March 31, 2013 at 11 regional stroke centers throughout Ontario, Canada from the Ontario Stroke Registry. Using administrative databases allowed researchers to link the registry with information about bone mineral density testing, prescription medications and deaths.

Of the 16,581 stroke survivors included in the study, only:The study also found that, while overall screening and treatment for osteoporosis and related conditions was low, certain stroke survivors were more likely to have bone mineral density testing. These people tended to be younger, female and to have had low-trauma fractures in the year after their stroke. Patients were more likely to be prescribed medications for osteoporosis post-stroke if they were female, already had osteoporosis, had previously broken bones, had previously had bone mineral density testing and had fallen or broken bones after their stroke.

"This study offers more evidence that there is a missed opportunity to identify people with stroke at increased risk of fractures, and to initiate treatment to prevent bone loss and fractures," Kapral said.
-end-
Co-authors are Eshita Kapoor, H.B.Sc.; Peter C. Austin, Ph.D.; Shabbir M. H. Alibhai, M.D., M.Sc.; Angela Cheung, M.D., Ph.D.; Peter Cram, M.D., M.B.A.; Leanna K. Casaubon, M.D., M.Sc.; Jiming Fang, Ph.D.; Joan Porter, M.Sc.; Eric E. Smith, M.D., Ph.D.; Marla Prager, M.D.; and Moira K. Kapral, M.D., M.Sc. Author disclosures are on the manuscript.

The Heart and Stroke Foundation of Canada funded the study.

Additional Resources:

Available multimedia is on right column of release link - https://newsroom.heart.org/news/many-stroke-patients-not-screened-for-osteoporosis-despite-known-risks?preview=658a948047156662b7751656b027af30

After April 25, view the manuscript online.
ACC/AHA Guidance for Preventing Heart Disease, Stroke Released
strokeassociation.org/
Follow AHA/ASA news on Twitter @HeartNews

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Stroke Association

The American Stroke Association is devoted to saving people from stroke -- the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit StrokeAssociation.org. Follow us on Facebook and Twitter.

American Heart Association

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.